Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
288
Frequently Asked Questions
What is Market Cap of Anika Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Anika Therapeutics Inc. market cap is $124.43M.
What is the 52-week high for Anika Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anika Therapeutics Inc. 52 week high is $26.00 as of September 12, 2025.
What is the 52-week low for Anika Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anika Therapeutics Inc. 52 week low is $7.87 as of September 12, 2025.
What is Anika Therapeutics Inc. stock price today?
Anika Therapeutics Inc. stock price today is $8.55.
What was Anika Therapeutics Inc. stock price yesterday?
Anika Therapeutics Inc. stock price yesterday was $8.63.
What is the PE ratio of Anika Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Anika Therapeutics Inc.’s P/E ratio is -2.08.
What is the Price-to-Book ratio of Anika Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Anika Therapeutics Inc. P/B ratio is 0.8426.
What is the 50-day moving average of Anika Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Anika Therapeutics Inc. 50-day moving average is $9.68.
How many employess does Anika Therapeutics Inc. has?